The Moment Of Truth For Three Alzheimer’s Drugs Beckons: What To Expect
Eisai/Biogen And Roche Phase III Readouts Expected Soon
After the Aduhelm controversy, there is hope these drugs could offer a true breakthrough for people with early stage Alzheimer's. • Source: Shutterstock
